327 related articles for article (PubMed ID: 25725765)
1. HPLC for confirmatory diagnosis and biochemical monitoring of Cuban patients with hyperphenylalaninemias.
Contreras J; Alonso E; Fuentes LE
MEDICC Rev; 2015 Jan; 17(1):23-8. PubMed ID: 25725765
[TBL] [Abstract][Full Text] [Related]
2. Cuban neonatal screening of phenylketonuria using an ultramicro-fluorometric test.
González EC; Frómeta A; del Río L; Castells E; Robaina MS; García SM; Licourt T; Arteaga AL; Martínez L
Clin Chim Acta; 2009 Apr; 402(1-2):129-32. PubMed ID: 19168043
[TBL] [Abstract][Full Text] [Related]
3. Use of phenylalanine-to-tyrosine ratio determined by tandem mass spectrometry to improve newborn screening for phenylketonuria of early discharge specimens collected in the first 24 hours.
Chace DH; Sherwin JE; Hillman SL; Lorey F; Cunningham GC
Clin Chem; 1998 Dec; 44(12):2405-9. PubMed ID: 9836704
[TBL] [Abstract][Full Text] [Related]
4. [Did the change of technique of screening investigations influence on improvement of test credibility in recognizing and differentiating diagnostics of hiperphenylalaninemias?].
Didycz B; Lemańska D; Słuszniak A
Przegl Lek; 2009; 66(1-2):11-3. PubMed ID: 19485249
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 6-year application of the enzymatic colorimetric phenylalanine assay in the setting of neonatal screening for phenylketonuria.
Schulze A; Mayatepek E; Hoffmann GF
Clin Chim Acta; 2002 Mar; 317(1-2):27-37. PubMed ID: 11814455
[TBL] [Abstract][Full Text] [Related]
6. Multivariate discrimination for phenylketonuria (PKU) and non-PKU hyperphenylalaninemia after analysis of newborns' dried blood-spot specimens for six amino acids by ion-exchange chromatography.
Reilly AA; Bellisario R; Pass KA
Clin Chem; 1998 Feb; 44(2):317-26. PubMed ID: 9474031
[TBL] [Abstract][Full Text] [Related]
7. Newborn phenylketonuria (PKU) Guthrie (BIA) screening and early hospital discharge.
Hanley WB; Demshar H; Preston MA; Borczyk A; Schoonheyt WE; Clarke JT; Feigenbaum A
Early Hum Dev; 1997 Jan; 47(1):87-96. PubMed ID: 9118832
[TBL] [Abstract][Full Text] [Related]
8. Phenylketonuria: contemporary screening and diagnosis.
Mabry CC
Ann Clin Lab Sci; 1990; 20(6):393-7. PubMed ID: 2073089
[TBL] [Abstract][Full Text] [Related]
9. Phenylketonuria variants in Ontario.
Can Med Assoc J; 1976 Sep; 115(6):509-12. PubMed ID: 953933
[TBL] [Abstract][Full Text] [Related]
10. Use of the phenylalanine:tyrosine ratio to test newborns for phenylketonuria in a large public health screening programme.
Eastman JW; Sherwin JE; Wong R; Liao CL; Currier RJ; Lorey F; Cunningham G
J Med Screen; 2000; 7(3):131-5. PubMed ID: 11126161
[TBL] [Abstract][Full Text] [Related]
11. Determination of Phenylalanine and Tyrosine by High Performance Liquid Chromatography-Tandem Mass Spectrometry.
Peat J; Garg U
Methods Mol Biol; 2016; 1378():219-25. PubMed ID: 26602133
[TBL] [Abstract][Full Text] [Related]
12. Phenylketonuria: screening, treatment and maternal PKU.
Matalon R; Michals K
Clin Biochem; 1991 Aug; 24(4):337-42. PubMed ID: 1959225
[TBL] [Abstract][Full Text] [Related]
13. Neonatal phenylalanine wash-out in phenylketonuria.
Porta F; Ponzone A; Spada M
Metab Brain Dis; 2020 Oct; 35(7):1225-1229. PubMed ID: 32661828
[TBL] [Abstract][Full Text] [Related]
14. [What disorders suspect following an increase of phenylalanine on newborn screening?].
Michel MA; Raucourt E; Bednarek N; Garnotel R
Ann Biol Clin (Paris); 2014; 72(2):193-6. PubMed ID: 24736139
[TBL] [Abstract][Full Text] [Related]
15. 5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics.
Levy H; Lamppu D; Anastosoaie V; Baker JL; DiBona K; Hawthorne S; Lindenberger J; Kinch D; Seymour A; McIlduff M; Watling S; Vockley J
Mol Genet Metab; 2020 Mar; 129(3):177-185. PubMed ID: 31883647
[TBL] [Abstract][Full Text] [Related]
16. Management of phenylketonuria and hyperphenylalaninemia.
de Baulny HO; Abadie V; Feillet F; de Parscau L
J Nutr; 2007 Jun; 137(6 Suppl 1):1561S-1563S; discussion 1573S-1575S. PubMed ID: 17513425
[TBL] [Abstract][Full Text] [Related]
17. Newborn phenylalanine/tyrosine metabolism. Implications for screening for phenylketonuria.
Schneider AJ
Am J Dis Child; 1983 May; 137(5):427-32. PubMed ID: 6846269
[TBL] [Abstract][Full Text] [Related]
18. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
[TBL] [Abstract][Full Text] [Related]
19. Optimizing the Phenylalanine Cut-Off Value in a Newborn Screening Program.
Perko D; Repic Lampret B; Remec ZI; Zerjav Tansek M; Drole Torkar A; Krhin B; Bicek A; Oblak A; Battelino T; Groselj U
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328070
[TBL] [Abstract][Full Text] [Related]
20. [Serum tyrosine in children with phenylketonuria and mild hyperphenylalaninemia].
Cabalska B; Nowacka M; Laskowska-Klita T; Nowaczewska I; Zorska K; Taljański W
Med Wieku Rozwoj; 2000; 4(1):5-12. PubMed ID: 11013857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
